CORNELIU ILEA: Open Payments
NPI 1114573151 · WESTBROOK, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$913 in 40 payments from 17 companies in 2025. Trend: 2023 $398 · 2024 $189 · 2025 $913
Food & beverage: $913
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $163 |
| Daiichi Sankyo Inc. | 7 | $140 |
| AstraZeneca Pharmaceuticals LP | 6 | $139 |
| Janssen Biotech, Inc. | 2 | $61 |
| Merck Sharp & Dohme LLC | 3 | $56 |
| E.R. Squibb & Sons, L.L.C. | 2 | $48 |
| SOBI, INC | 2 | $43 |
| Novocure Inc. | 1 | $41 |
| ADC THERAPEUTICS AMERICA, INC. | 2 | $35 |
| Novartis Pharmaceuticals Corporation | 2 | $30 |
Products named: EPKINLY, Enhertu, TAGRISSO, ERLEADA, OPDIVO, Vanflyta, Vonjo, Optune Lua (NovoTTF-200T).
Industry payments across ME — which companies pay providers there.
